Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcitriol and Dexamethasone in Localized Prostate Cancer
NCT00084864Phase 2Terminated
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- Sep 2002
- Primary completion
- Feb 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of calcitriol in prostate cancer (PCa), sponsored by Roswell Park Comprehensive Cancer Center. Primary endpoint: Effect of Preoperative High-dose Calcitriol and Dexamethasone on Prostatic Tumor Vessel Density at 12 months. Started Sep 2002; status: terminated.
02
Drugs
calcitriol
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00084864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00084864.